Yanli Nie Wenjia Sun Zhihua Xiao Shengwei Ye
10.1097/MD.0000000000014060
Medicine (Baltimore)
2019 Jan;98(3):e14060.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/30653116/
Antineoplastic Agents / administration & dosage Gastrointestinal Stromal Tumors / drug therapy Jejunal Neoplasms / drug therapy Sunitinib / administration & dosage
Antineoplastic Agents / administration & dosage Gastrointestinal Stromal Tumors / drug therapy Jejunal Neoplasms / drug therapy Sunitinib / administration & dosage Case Reports Adult Drug Administration Schedule Drug Resistance, Neoplasm / drug effects Drug Resistance, Neoplasm / genetics Exons Gastrointestinal Stromal Tumors / genetics Humans Induction Chemotherapy Jejunal Neoplasms / genetics Male Mutation Proto-Oncogene Proteins c-kit / drug effects Proto-Oncogene Proteins c-kit / genetics Time Factors Treatment Outcome Antineoplastic Agents KIT protein, human Proto-Oncogene Proteins c-kit Sunitinib
PMC6370167
30653116
Complete response to sunitinib for more than three years in a patient with a jejunum gastrointestinal stromal tumor: A case report
2019